Walder Wyss advised Nasdaq-listed CRISPR Therapeutics, as the Switzerland-based biopharmaceutical company issued a USD 600 million aggregate principal amount of convertible senior notes. The convertible senior notes were offered in a private offering to qualified institutional
Tags :Walder Wyss
Walder Wyss advised Xsensio, as the Swiss deep-tech company closed a USD 7 million series A financing round. San Francisco-based venture capital firm WI Harper led the round, with participation from Privilège Ventures, the European
Walder Wyss advised J. Safra Sarasin Group, a private bank specialised in wealth and asset management, in connection with its acquisition of approximately 71% in Saxo Bank, an international FinTech bank for investors, traders, and institutional
Walder Wyss advised real estate service provider Ista in connection with the acquisition — by the company’s Swiss subsidiary Ista Swiss — of Blockstrom, a specialist in digital energy data management and ZEV solutions. The Walder
Walder Wyss was actively involved in the development of the Enforcement Aid for assessing climate-related claims, published by the Federal Office for the Environment (FOEN) in accordance with the revised Federal Act against Unfair Competition (
Walder Wyss advised Swiss TEPU Holding, which consists of the companies Pfanner & Frei and re.com Elektroanlagen, on the sale of majority stakes to the TSG Group, a European provider of technical services for
Walder Wyss advised UVC Partners, a venture capital firm headquartered in Berlin and Munich, in connection with its role as lead investor in the USD 24 million financing round of Metafuels, a sustainable aviation fuel specialist
Walder Wyss advised Garage Auto Kunz, a family-owned Swiss car dealership, on its sale to Gross Garage Gruppe. Headquartered in Wohlen, Garage Auto Kunz is a parallel and direct importer, active across Switzerland and focusing
Walder Wyss — in collaboration with Italian firm Giovannelli e Associati — advised ReeVo, a Milan-based European cloud provider and managed security service provider, on its acquisition of Lugano-based Security Lab Group, a Swiss cybersecurity specialist. The
Walder Wyss advised WindRose Health Investors, as the company led the acquisition by its subsidiary SubjectWell of Swiss-based Clariness. The deal results in the formation of a globally active, full-service patient recruitment platform. The Walder